July 2, 2022

autosankauf-emsdetten.de

WEBSITE NEWS UPDATE

Stocks With Rising Relative Price Strength: ChemoCentryx

2 min read

On Friday, ChemoCentryx (CCXI) reached a key technical benchmark, seeing its Relative Strength (RS) Rating jump into the 80-plus percentile with an improvement to 80, up from 63 the day before.




X



When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock’s price action over the last 52 weeks matches up against other publicly traded companies.

Over 100 years of market history reveals that the stocks that go on to make the biggest gains tend to have an 80 or better RS Rating as they launch their biggest climbs.


See How IBD Helps You Make More Money In Stocks


Now is not an ideal time to jump in since it isn’t near a proper buy zone, but see if the stock manages to form a consolidation and break out.

ChemoCentryx posted negative growth for both sales and earnings last quarter. The company is expected to release its next quarterly numbers on or around Apr. 29.

The company earns the No. 155 rank among its peers in the Medical-Biomed/Biotech industry group. Vertex Pharmaceuticals (VRTX) and Amphastar Pharmaceutcls (AMPH) are also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

Biotech And Pharmaceutical Industry And Stock News

Which Stocks Are Showing Improved Price Performance?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Copyright © All rights reserved. | Newsphere by AF themes.